HK1133991A1 - Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of lice - Google Patents
Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of liceInfo
- Publication number
- HK1133991A1 HK1133991A1 HK10102016.4A HK10102016A HK1133991A1 HK 1133991 A1 HK1133991 A1 HK 1133991A1 HK 10102016 A HK10102016 A HK 10102016A HK 1133991 A1 HK1133991 A1 HK 1133991A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- avermectin
- lice
- elimination
- susceptible
- resistant strains
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85135206P | 2006-10-12 | 2006-10-12 | |
US97625907P | 2007-09-28 | 2007-09-28 | |
PCT/US2007/081258 WO2008067054A2 (fr) | 2006-10-12 | 2007-10-12 | Formulations topiques d'avermectine et procédés d'élimination et de prophylaxie de souches de poux susceptibles et résistantes au traitement |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1133991A1 true HK1133991A1 (en) | 2010-04-16 |
Family
ID=39468571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10102016.4A HK1133991A1 (en) | 2006-10-12 | 2010-02-25 | Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of lice |
Country Status (6)
Country | Link |
---|---|
US (9) | US8791153B2 (fr) |
EP (2) | EP2653160B1 (fr) |
CA (1) | CA2666365C (fr) |
ES (1) | ES2653259T3 (fr) |
HK (1) | HK1133991A1 (fr) |
WO (1) | WO2008067054A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2666365C (fr) | 2006-10-12 | 2016-08-09 | Topaz Pharmaceuticals Llc | Formulations topiques d'avermectine et procedes d'elimination et de prophylaxie de souches de poux susceptibles et resistantes au traitement |
EP2155190A4 (fr) * | 2007-05-04 | 2010-12-08 | Topaz Pharmaceuticals Inc | Formulations topiques et procédés d'élimination et de prophylaxie de souches de poux susceptibles et résistantes au traitement avec de multiples modes d'action |
US8475510B2 (en) | 2008-09-23 | 2013-07-02 | Larada Sciences, Inc. | Airflow applicators and related treatment methods |
WO2010051348A1 (fr) * | 2008-10-29 | 2010-05-06 | Topaz Pharmaceuticals Inc. | Système de conservation pour formulations topiques thérapeutiques à base d'émulsion |
TWI474841B (zh) * | 2009-10-29 | 2015-03-01 | Topaz Pharmaceuticals Inc | 乳劑基治療局部製劑的保存系統 |
EA021622B1 (ru) | 2009-11-02 | 2015-07-30 | Меда Аб | Композиции, включающие флавоноидсодержащие экстракты из растений рода citrus, и их применение в качестве средства лечения педикулеза |
US8174322B2 (en) | 2010-05-04 | 2012-05-08 | Nxp B.V. | Power control of reconfigurable outphasing chireix amplifiers and methods |
EP3326614A1 (fr) * | 2016-11-24 | 2018-05-30 | Nestlé Skin Health SA | Composition comprenant des composés d'avermectine sans solvants et agents pro-pénétrants de composés d'avermectine |
EP3326609A1 (fr) * | 2016-11-24 | 2018-05-30 | Nestlé Skin Health SA | Composition comprenant des composés d'avermectine sans agents de gélification |
EP3326608A1 (fr) | 2016-11-24 | 2018-05-30 | Nestlé Skin Health SA | Composition comprenant des composés d'avermectine sans matières grasses solides |
JP2021050170A (ja) * | 2019-09-26 | 2021-04-01 | 株式会社大阪製薬 | シラミ駆除剤 |
EP4062907A1 (fr) | 2021-03-23 | 2022-09-28 | Substipharm | Formulation par voie orale d'ivermectine et utilisations |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US180352A (en) * | 1876-07-25 | Improvement in parlor shooting-galleries | ||
US4199569A (en) | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
US4444865A (en) * | 1981-11-12 | 1984-04-24 | Eastman Kodak Company | Blended grain direct-positive emulsions and photographic elements and processes for their use |
EP0179583A1 (fr) | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | Système pour augmenter la vitesse de dissolution dans l'eau et la solubilité de médicaments peu solubles |
US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
WO1997044034A1 (fr) * | 1996-05-20 | 1997-11-27 | Otsuka Pharmaceutical Co., Ltd. | Remede pour le traitement de l'acne rosacee |
US6426333B1 (en) * | 1996-09-19 | 2002-07-30 | Merial | Spot-on formulations for combating parasites |
FR2753377B1 (fr) * | 1996-09-19 | 1999-09-24 | Rhone Merieux | Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides |
WO1998036730A2 (fr) * | 1997-02-21 | 1998-08-27 | Beiersdorf Ag | Compositions de traitement de l'acne rosacee |
US6107397A (en) * | 1997-03-24 | 2000-08-22 | Basf Aktiengesellschaft | Aqueous copolymer dispersions of water-soluble monomers with N-vinyl groups and hydrophobic monomers |
US6006758A (en) * | 1998-02-03 | 1999-12-28 | University Of Maryland | Method and device for the detection and removal of head lice |
US20040166183A1 (en) * | 1998-05-20 | 2004-08-26 | Ruseler-Van Embden Johanna G. H. | Methods and means for preventing or treating inflammation or pruritis |
US6103248A (en) * | 1998-05-22 | 2000-08-15 | Burkhart; Craig G. | Topical preparation and therapy for head lice |
PL197431B1 (pl) * | 1998-07-02 | 2008-03-31 | Lilly Co Eli | Szampon do zwalczania wszawicy u ludzi, preparat przeciw wszawicy kondycjonujący włosy, płukanka przeciw wszawicy, zastosowanie spinozyny lub jej pochodnej lub soli do wytwarzania leku do leczenia wszawicy |
US5952372A (en) * | 1998-09-17 | 1999-09-14 | Mcdaniel; William Robert | Method for treating rosacea using oral or topical ivermectin |
US6524602B1 (en) | 1998-10-13 | 2003-02-25 | Craig G. Burkhart | Polymer delivery system in treatments for parasitic skin diseases |
JP2002535268A (ja) | 1999-01-25 | 2002-10-22 | オプティム セラピューティクス, インコーポレイテッド | リポソーム処方物 |
US6265384B1 (en) * | 1999-01-26 | 2001-07-24 | Dale L. Pearlman | Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents |
US6262031B1 (en) * | 1999-03-12 | 2001-07-17 | Merck & Co., Inc. | Method for treating pediculosis capitisinfestation |
US6927210B1 (en) * | 1999-08-12 | 2005-08-09 | Eli Lilly And Company | Ectoparasiticidal aqueous suspension formulations of spinosyns |
EA004251B1 (ru) | 1999-08-12 | 2004-02-26 | Эли Лилли Энд Компани | Эктопаразитицидные водные суспензионные препараты спинозинов |
US20030180352A1 (en) | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6399651B1 (en) | 2000-06-29 | 2002-06-04 | L. Dean Parks | Method of treating dermatoses using avermectin compound |
US6319945B1 (en) * | 2000-06-29 | 2001-11-20 | L. Dean Parks | Method of treatment of seborrheic dermatitis |
US6399652B1 (en) * | 2000-06-29 | 2002-06-04 | L. Dean Parks | Method of treating acne vulgaris using avermectin compound |
US7897559B2 (en) * | 2000-06-29 | 2011-03-01 | Parks L Dean | Dermatological composition and kit containing avermectin compound for treating dermatological conditions |
US6727228B2 (en) | 2001-04-25 | 2004-04-27 | Johnson & Johnson Consumer Companies, Inc. | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
US20030040504A1 (en) * | 2001-05-09 | 2003-02-27 | Gans Eugene H. | Ectoparasiticidal compositions and methods of their use |
ES2365993T5 (es) | 2001-09-17 | 2020-06-25 | Elanco Us Inc | Formulaciones pesticidas |
EP1476121A4 (fr) * | 2002-02-08 | 2010-10-27 | Merck Sharp & Dohme | Composition topique d'ivermectine |
US20040097377A1 (en) * | 2002-03-21 | 2004-05-20 | Hahn Donald R. | Pesticidal spinosyn derivates |
US6663876B2 (en) * | 2002-04-29 | 2003-12-16 | Piedmont Pharmaceuticals, Llc | Methods and compositions for treating ectoparasite infestation |
US8119150B2 (en) * | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
FR2854074B1 (fr) * | 2003-04-24 | 2007-11-23 | Galderma Res & Dev | Utilisation de l'ivermectine pour le traitement de desordres dermatologiques |
MXPA05011208A (es) * | 2003-04-24 | 2005-12-14 | Galderma Sa | Uso de ivermectina para el tratamiento de desordenes dermatologicos. |
US6927206B2 (en) * | 2003-06-06 | 2005-08-09 | Procyte Corporation | Compositions and methods for treatment of rosacea |
WO2005000241A2 (fr) | 2003-06-23 | 2005-01-06 | Macrochem Corporation | Compositions et procedes pour administration topique |
US20050095215A1 (en) * | 2003-11-03 | 2005-05-05 | Popp Karl F. | Antimicrobial shampoo compositions |
US20050220742A1 (en) * | 2004-03-31 | 2005-10-06 | Breen Ed V | Compositions and methods for maintaining eyelid hygiene |
EP1744763B1 (fr) | 2004-04-29 | 2010-01-06 | Eli Lilly And Company | Spinosynes pour la guérison des blessures |
DE102004025357B4 (de) * | 2004-05-19 | 2007-03-29 | Beiersdorf Ag | Emulsionskonzentrat mit wasserlöslichen und öllöslichen Polymeren und kosmetische Zubereitung enthaltend Emulsionskonzentrat sowie ein Verfahren zu dessen Herstellung und dessen Verwendung |
EP1609460A1 (fr) | 2004-06-24 | 2005-12-28 | The Procter & Gamble Company | Compositions de soin pour la peau comprenant un corps gras ayant un domaine de fusion de 21-40 C |
CA2666365C (fr) | 2006-10-12 | 2016-08-09 | Topaz Pharmaceuticals Llc | Formulations topiques d'avermectine et procedes d'elimination et de prophylaxie de souches de poux susceptibles et resistantes au traitement |
EP2155190A4 (fr) * | 2007-05-04 | 2010-12-08 | Topaz Pharmaceuticals Inc | Formulations topiques et procédés d'élimination et de prophylaxie de souches de poux susceptibles et résistantes au traitement avec de multiples modes d'action |
WO2010051348A1 (fr) * | 2008-10-29 | 2010-05-06 | Topaz Pharmaceuticals Inc. | Système de conservation pour formulations topiques thérapeutiques à base d'émulsion |
-
2007
- 2007-10-12 CA CA2666365A patent/CA2666365C/fr active Active
- 2007-10-12 WO PCT/US2007/081258 patent/WO2008067054A2/fr active Application Filing
- 2007-10-12 EP EP13176927.5A patent/EP2653160B1/fr active Active
- 2007-10-12 EP EP07871159.5A patent/EP2091325B1/fr active Active
- 2007-10-12 ES ES13176927.5T patent/ES2653259T3/es active Active
- 2007-10-12 US US11/871,660 patent/US8791153B2/en active Active
-
2010
- 2010-02-25 HK HK10102016.4A patent/HK1133991A1/xx unknown
-
2011
- 2011-05-26 US US13/116,547 patent/US8927595B2/en active Active
-
2014
- 2014-12-16 US US14/572,664 patent/US20150105340A1/en not_active Abandoned
-
2017
- 2017-01-18 US US15/408,924 patent/US20170118985A1/en not_active Abandoned
-
2018
- 2018-05-01 US US15/968,364 patent/US20180242584A1/en not_active Abandoned
- 2018-11-29 US US16/204,976 patent/US20190166844A1/en not_active Abandoned
-
2020
- 2020-03-20 US US16/825,476 patent/US11229207B2/en active Active
-
2021
- 2021-12-13 US US17/549,298 patent/US20220095621A1/en not_active Abandoned
-
2022
- 2022-02-08 US US17/667,424 patent/US20220159961A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2653160B1 (fr) | 2017-09-27 |
EP2091325A2 (fr) | 2009-08-26 |
US11229207B2 (en) | 2022-01-25 |
US20200221700A1 (en) | 2020-07-16 |
WO2008067054A3 (fr) | 2008-12-18 |
US20220095621A1 (en) | 2022-03-31 |
US20080214657A1 (en) | 2008-09-04 |
ES2653259T3 (es) | 2018-02-06 |
EP2091325B1 (fr) | 2014-08-06 |
US20220159961A1 (en) | 2022-05-26 |
US20190166844A1 (en) | 2019-06-06 |
US8791153B2 (en) | 2014-07-29 |
CA2666365A1 (fr) | 2008-06-05 |
US20110275582A1 (en) | 2011-11-10 |
EP2653160A1 (fr) | 2013-10-23 |
CA2666365C (fr) | 2016-08-09 |
US8927595B2 (en) | 2015-01-06 |
US20170118985A1 (en) | 2017-05-04 |
US20180242584A1 (en) | 2018-08-30 |
EP2091325A4 (fr) | 2010-12-15 |
WO2008067054A2 (fr) | 2008-06-05 |
US20150105340A1 (en) | 2015-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1133991A1 (en) | Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of lice | |
IL269370B (en) | Chemicals, preparations and methods for the treatment and prevention of orthopoxvirus infections and related diseases | |
IL250858A0 (en) | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections | |
IL253038A0 (en) | Preparations and methods for the treatment or prevention of infections. my voice | |
IL195142A (en) | Processed arylaimidazolone and triazolone, their preparation process, pharmaceutical preparations containing them for the treatment or prevention of diseases | |
HK1134679A1 (zh) | 用於治療感染的組合物和方法 | |
WO2006013441A3 (fr) | Utilisation de bacteries probiotiques dans la preparation de compositions topiques destinees a la protection de la peau | |
HK1113085A1 (en) | Compounds, compositions and methods for the treatment of poxvirus infections | |
EP2192901A4 (fr) | Agents chimiques, compositions et procédés de traitement et de prévention des infections à orthopoxvirus et des maladies associées | |
WO2010090860A3 (fr) | Méthodes de traitement d'une infection bactérienne et compositions associées | |
HK1180237A1 (zh) | 抗微生物肽,組合物和使用方法 | |
GB0718446D0 (en) | Compositions and methods for the treatment of infection | |
IL195272A0 (en) | Methods and compositions for the treatment of viral infections | |
ZA200709520B (en) | Use of TFPI to treat severe bacterial infections | |
ZA201101517B (en) | Compositions for the prophylaxis and treatment of dermatological/mucosal diseases,and uses thereof | |
PL2111855T3 (pl) | Kompozycje przeciwbakteryjne do leczenia infekcji górnych i dolnych dróg oddechowych | |
WO2008097364A3 (fr) | Utilisation de l'oritavancine pour la prévention et le traitement de l'anthrax | |
IL210975A (en) | Annapomapungin History, Pharmaceuticals Containing Them and Their Use in Preparing Medicines to Treat Fungal Infections | |
ZA200809686B (en) | Lysobactin amindes | |
IL206104A (en) | Aminazoles, pharmaceuticals containing them and their use in the preparation of bacterial infections | |
PL2134742T3 (pl) | Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt | |
EP2326340A4 (fr) | Compositions et procédés destinés à traiter une infection par s. pneumoniae | |
WO2007070536A3 (fr) | Agents antibacteriens 7-quinolyl cetolide | |
EP2328611A4 (fr) | Compositions et procédés destinés à traiter une infection par s. pneumoniae | |
IL211282A0 (en) | Compositions and use thereof for treating s. pneumoniae infection |